[CYCC] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
28-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- -11.91%
YoY- -19.64%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 4 29 31 16 373 0 0 -
PBT -3,669 -7,225 -6,093 -6,699 -6,034 -7,124 -9,000 -45.05%
Tax -412 -4,279 -822 -602 -586 -1,320 -1,581 -59.23%
NP -3,257 -2,946 -5,271 -6,097 -5,448 -5,804 -7,419 -42.26%
Tax Rate - - - - - - - -
Total Cost 3,261 2,975 5,302 6,113 5,821 5,804 7,419 -42.21%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin -81,425.00 -10,158.62 -17,003.23 -38,106.25 -1,460.59 0.00 0.00 -
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -1.80 -2.27 -6.17 -7.23 -6.51 -6.94 -8.87 -65.50%
EPS Diluted -1.80 -2.27 -6.17 -7.23 -6.51 -6.94 -8.87 -65.50%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.